Cargando…
Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses
Breast cancer (BC) is the most frequently diagnosed cancer in women, with many patients experiencing recurrence following treatment. Antigens delivered on virus-like particles (VLPs) induce a targeted immune response and here we investigated whether the co-delivery of multiple antigens could induce...
Autores principales: | Campbell, Katrin, Young, Vivienne L., Donaldson, Braeden C., Woodall, Matthew J., Shields, Nicholas J., Walker, Greg F., Ward, Vernon K., Young, Sarah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148150/ https://www.ncbi.nlm.nih.gov/pubmed/34066318 http://dx.doi.org/10.3390/vaccines9050463 |
Ejemplares similares
-
Adoptive cell therapy with CD4(+) T helper 1 cells and CD8(+) cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes
por: Li, Kunyu, et al.
Publicado: (2017) -
Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014) -
Dry Formulation of Virus-Like Particles in Electrospun Nanofibers
por: Dowlath, Sasheen, et al.
Publicado: (2021) -
An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy
por: Jemon, Khairunadwa, et al.
Publicado: (2013) -
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)